Commentary

[摘要] Symptomatic CCB toxicity remains a challenging entity to treat. It seems intuitive that calcium salts should overcome the competitive inhibition of the L-type calcium channels. Although calcium salts are usually the first treatment, they are seldom very effective as the primary treatment. Extreme hypercalcemia carries some risks. Monitoring calcium concentrations is important for patient safety when using repeated doses or constant infusions of calcium salts.Calcium salts for intravenous use are available …

[学科分类] 过敏症与临床免疫学